These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22575163)

  • 1. Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): impact on the timeliness of uptake of the primary course of DTPa vaccine.
    Wendy B
    Vaccine; 2012 Jul; 30(35):5293-7. PubMed ID: 22575163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience.
    Hull BP; Menzies R; Macartney K; McIntyre PB
    Vaccine; 2013 Apr; 31(15):1964-9. PubMed ID: 23422140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timeliness and factors associated with rotavirus vaccine uptake among Australian Aboriginal and non-Aboriginal children: A record linkage cohort study.
    Fathima P; Gidding HF; Snelling TL; McIntyre PB; Blyth CC; Sheridan S; Liu B; de Klerk N; Moore HC
    Vaccine; 2019 Sep; 37(39):5835-5843. PubMed ID: 31443995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007.
    Anh DD; Carlos CC; Thiem DV; Hutagalung Y; Gatchalian S; Bock HL; Smolenov I; Suryakiran PV; Han HH
    Vaccine; 2011 Mar; 29(11):2029-36. PubMed ID: 21256876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines.
    Luna-Casas G; Juliao P; Carreño-Manjarrez R; Castañeda-Prado A; Cervantes-Apolinar MY; Navarro-Rodriguez R; Sánchez-González G; Cortés-Alcalá R; DeAntonio R
    Hum Vaccin Immunother; 2019; 15(6):1251-1259. PubMed ID: 30380975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
    Kirkwood CD; Boniface K; Barnes GL; Bishop RF
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.
    Abbott C; Tiede B; Armah G; Mahmoud A
    Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of G2P[4] rotavirus strains associated with increased detection in Australian states using the RotaTeq® vaccine during the 2010-2011 surveillance period.
    Donato CM; Zhang ZA; Donker NC; Kirkwood CD
    Infect Genet Evol; 2014 Dec; 28():398-412. PubMed ID: 24861815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua.
    Orozco M; Vasquez J; Pedreira C; De Oliveira LH; Amador JJ; Malespin O; Andrus J; Tate J; Parashar U; Patel M
    J Infect Dis; 2009 Nov; 200 Suppl 1():S125-30. PubMed ID: 19821709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
    Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
    Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
    Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.